The proteasome inhibitor bortezomib interacts synergistically with histone deacetylase inhibitors to induce apoptosis in Bcr/Abl cells sensitive and resistant to STI571. (Q44534289)
Jump to navigation
Jump to search
scientific article published on 31 July 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The proteasome inhibitor bortezomib interacts synergistically with histone deacetylase inhibitors to induce apoptosis in Bcr/Abl cells sensitive and resistant to STI571. |
scientific article published on 31 July 2003 |
Statements
1 reference
The proteasome inhibitor bortezomib interacts synergistically with histone deacetylase inhibitors to induce apoptosis in Bcr/Abl cells sensitive and resistant to STI571. (English)
1 reference
Paul Dent
1 reference
Chunrong Yu
1 reference
Mohamed Rahmani
1 reference
Daniel Conrad
1 reference
Mark Subler
1 reference
Steven Grant
1 reference
31 July 2003
1 reference
1 reference
102
1 reference
10
1 reference
3765-3774
1 reference
Identifiers
1 reference
1 reference